Jerry Gurwitz to Prescription Drugs
This is a "connection" page, showing publications Jerry Gurwitz has written about Prescription Drugs.
Connection Strength
0.600
-
Fischer SH, Tjia J, Reed G, Peterson D, Gurwitz JH, Field TS. Factors associated with ordering laboratory monitoring of high-risk medications. J Gen Intern Med. 2014 Dec; 29(12):1589-98.
Score: 0.112
-
Harrold LR, Gurwitz JH, Briesacher BA. Dr. Harrold, et al reply. J Rheumatol. 2013 Aug; 40(8):1462.
Score: 0.105
-
Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, Gurwitz JH, Soumerai SB. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013 Feb; 40(2):137-43.
Score: 0.101
-
Fischer SH, Field TS, Gagne SJ, Mazor KM, Preusse P, Reed G, Peterson D, Gurwitz JH, Tjia J. Patient completion of laboratory tests to monitor medication therapy: a mixed-methods study. J Gen Intern Med. 2013 Apr; 28(4):513-21.
Score: 0.100
-
Tjia J, Field TS, Fischer SH, Gagne SJ, Peterson DJ, Garber LD, Gurwitz JH. Quality measurement of medication monitoring in the "meaningful use" era. Am J Manag Care. 2011 Sep; 17(9):633-7.
Score: 0.092
-
Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc. 2011 Aug; 59(8):1513-20.
Score: 0.091